Abnormal expression of gastric mucin in human and rat aberrant crypt foci during colon carcinogenesis

Tumor Biology

Volumn 24, Issue 3, 2003, Pages 109-115

  Bara, J ^a   Forgue Lafitte, M E ^a   Maurin, N ^a   Flejou J F ^a   Zimber, A ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Aberrant crypt foci; Carcinogenesis; Colon; Gastric mucin; Human; M1; MNNG; MUC5AC; Rat

Indexed keywords

GASTRIN; GUANIDINE DERIVATIVE; METHYLNITRONITROSOGUANIDINE; MONOCLONAL ANTIBODY; MUCIN; MUCIN 1; MUCIN 5; PEROXIDASE; PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CANCER PATIENT; CARCINOGENESIS; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE MARKER; DNA MODIFICATION; GENETIC CODE; GENETIC STRAIN; GOBLET CELL; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOPEROXIDASE STAINING; INTESTINE CRYPT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN;

EID: 0345689551     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073840     Document Type: Article

References (33)

1. Bara J, Languille O, Gendron MC, Daher N, Martin E, Burtin P: Immunohistological study of precancerous mucus modification in human distal colonic polyps. Cancer Res 1983;43:3885-3891.
2. Bara J, Andre J, Gautier R, Burtin P: Abnormal pattern of mucus-associated M1 antigens in histologically normal mucosa adjacent to colonic adenocarcinomas. Cancer Res 1984;44:4040-4045.
3. Decaens C, Bara J, Rosa B, Daher N, Burtin P: Early oncofetal antigenic modifications during rat colonic carcinogenesis. Cancer Res 1983;43:355-362.
4. Bara J, Chastre E, Mahiou J, Singh RL, Forgue-Lafitte ME, Hollande E, Gadeau F: Gastric M1 mucin, an early oncofetal marker of colon carcinogenesis, is encoded by the MUC5AC gene. Int J Cancer 1998;75:767-773.
5. Nollet S, Forgue-Lafitte ME, Kirkham P, Bara J: Mapping of two new epitopes on the apomucin encoded by MUC5AC gene: Expression in normal GI tract and colon tumors. Int J Cancer 2002;99:336-343.
6. Bara J, Nollet S, Forgue-Lafitte ME, Okada Y, Escande F, Buisine MP, Kirkham P: Mapping of SOMU1 and M1 epitopes on the MUC5AC apomucin, an early marker of pancreas and colon carcinogenesis (abstract). Tumor Biol 2002;23(S1):25.
7. Bird RP: Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings. Cancer Lett 1987;37:147-151.
8. Fenoglio-Preiser CM, Noffsinger A: Aberrant crypt foci: A review. Toxicol Pathol 1999;27:632-642.
9. Jass JR, Whitehall VL, Young J, Leggett BA: Emerging concepts in colorectal neoplasia. Gastroenterology 2002;123:862-876.
10. Smith AJ, Stern HS, Penner M, Hay K, Mitri A, Bapat BV, Gallinger S: Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 1994;54:5527-5530.
11. Augenlicht LH, Richards C, Corner G, Pretlow TP: Evidence for genomic instability in human colonic aberrant crypt foci. Oncogene 1996;12:1767-1772.
12. Heinen CD, Shivapurkar N, Tang Z, Groden J, Alabaster O: Microsatellite instability in aberrant crypt foci from human colons. Cancer Res 1996;56:5339-5341.
13. Pedroni M, Sala E, Scarselli A, Borghi F, Menigatti M, Benatti P, Percesepe A, Rossi G, Foroni M, Losi L, Di Gregorio C, DePol A, Nascimbeni R, DiBetta E, Salerni B, de Leon MP, Roncucci L: Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis. Cancer Res 2001;61:896-899.
14. Pretlow TP, O'Riordan MA, Spancake KM, Pretlow TG: Two types of putative preneoplastic lesions identified by hexosaminidase activity in whole-mounts of colons from F344 rats treated with carcinogen. Am J Pathol 1993;142:1695-1700.
15. Uchida K, Kado S, Ando M, Nagata Y, Takagi A, Onoue M: A mucinous histochemical study on malignancy of aberrant crypt foci (ACF) in rat colon. J Vet Med Sci 2001;63:145-149.
16. Hardy RG, Tselepis C, Hoyland J, Wallis Y, Pretlow TP, Talbot I, Sanders DS, Matthews G, Morton D, Jankowski JA: Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon. Gut 2002;50:513-519.
17. Bara J, Gautier R, Daher N, Zaghouani H, Decaens C: Monoclonal antibodies against oncofetal mucin M1 antigens associated with pre-cancerous colonic mucosae. Cancer Res 1986;46:3983-3989.
18. Parnaud G, Tache S, Peiffer G, Corpet DE: Polyethylene-glycol suppresses colon cancer and causes dose-dependent regression of azoxymethane-induced aberrant crypt foci in rats. Cancer Res 1999;59:5143-5147.
19. Decaens C, Gautier R, Bara J, Daher N, Le Pendu J, Burtin P: A new mucin-associated oncofetal antigen, a marker of early carcinogenesis in rat colon. Cancer Res 1988;48:1571-1577.
20. Decaens C, Nardelli J, Bara J, Burtin P: Biochemical characterization of a rat oncofetal colonic antigen defined by a monoclonal antibody raised against gastric surface epithelium. Biochem J 1993;293(pt 2):531-536.
21. Buisine MP, Janin A, Maunoury V, Audie JP, Delescaut MP, Copin MC, Colombel JF, Degand P, Aubert JP, Porchet N: Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma. Gastroenterology 1996;110:84-91.
22. Bartman AE, Sanderson SJ, Ewing SL, Niehans GA, Wiehr CL, Evans MK, Ho SB: Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps. Int J Cancer 1999;80:210-218.
23. Zimber A, Nollet S, Forgue-Lafitte ME, Maurin N, Gespach C, Bara J: Dual effect of bile acids in rat colon carcinogenesis and gastric oncofetal mucin as an early marker (abstract). 11th International Congress on Anti-Cancer Treatment, February 6-9, 2001, Paris, p 187.
24. Yao T, Nishiyama K, Oya M, Kouzuki T, Kajiwara M, Tsuneyoshi M: Multiple 'serrated adenocarcinomas' of the colon with a cell lineage common to metaplastic polyp and serrated adenoma. Case report of a new subtype of colonic adenocarcinoma with gastric differentiation. J Pathol 2000;190:444-449.
25. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996;87:159-170.
26. Vider BZ, Zimber A, Chastre E, Prevot S, Gespach C, Estlein D, Wolloch Y, Tronick SR, Gazit A, Yaniv A: Evidence for the involvement of the Wnt 2 gene in human colorectal cancer. Oncogene 1996;12:153-158.
27. Vider BZ, Zimber A, Hirsch D, Estlein D, Chastre E, Prevot S, Gespach C, Yaniv A, Gazit A: Human colorectal carcinogenesis is associated with deregulation of homeobox gene expression. Biochem Biophys Res Commun 1997;232:742-748.
28. Vider BZ, Zimber A, Chastre E, Gespach C, Halperin M, Mashiah P, Yaniv A, Gazit A: Deregulated expression of homeobox-containing genes, HOXB6, B8, C8, C9, and Cdx-1, in human colon cancer cell lines. Biochem Biophys Res Commun 2000;272:513-518.
29. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, van den Born M, Soete G, Pals S, Eilers M, Medema R, Clevers H: The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002;111:241-250.
30. Chawengsaksophak K, James R, Hammond VE, Kontgen F, Beck F: Homeosis and intestinal tumours in Cdx2 mutant mice. Nature 1997;386:84-87.
31. Beck F, Chawengsaksophak K, Waring P, Playford RJ, Furness JB: Reprogramming of intestinal differentiation and intercalary regeneration in Cdx2 mutant mice. Proc Natl Acad Sci USA 1999;96:7318-7323.
32. Buckhaults P, Rago C, St Croix B, Romans KE, Saha S, Zhang L, Vogelstein B, Kinzler KW: Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res 2001;61:6996-7001.
33. Traverso G, Shuber A, Levin B, Johnson C, Olsson L, Schoetz DJ, Hamilton SR, Boynton K, Kinzler KW, Vogelstein, B: Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 2002; 346:311-320.